Herpes Viral Origin of the Parsonage-Turner Syndrome: Highlighting of Serological Immune Anti-Herpes Deficiency Cured by Anti-Herpes Therapy

• Published in: Case reports in neurology 2015-05, Vol.7 (2), p.110-114
• Main Authors: Le Goaster, Jacqueline, Bourée, Patrice, Ifergan, Charles, Tangy, Frederic, Olivier, René, Haenni, Anne-Lise
• Format: Article
• Language: English
• Subjects: Appropriate anti-herpes therapy; Bilateral phrenic paralysis; Human health and pathology; Infectious diseases; Life Sciences; Neuralgic amyotrophy; Neurons and Cognition; Neurotropic herpes virus occurrences; Parsonage-Turner syndrome; Published: May 2015
• ISSN: 1662-680X; 1662-680X
• DOI: 10.1159/000381945

In 2012, a 50 year-old athletic male presented with weakness, pain and unilateral phrenic paralysis, followed by bilateral phrenic paralysis with deep dyspnea. In 2013, the Parsonage-Turner syndrome was diagnosed. When the patient was seen in September 2014 for the first time, he was facing phrenic neuromuscular failure, which led to the hypothesis of neurotropic herpes viruses. A control of the global serological anti-Herpes immunity to analyze his antibody (Ab) levels confirmed herpes immune genetic deficiency. An appropriate herpes chemotherapy treatment was proposed. Immediately, a spectacular recovery of the patient was observed, and after a few weeks, the respiratory function tests showed normal values. The hypothesis of the inductive role of viruses of the herpes family in the Parsonage-Turner syndrome was thus substantiated. The patient's immune deficiency covers the HSV2, HHV3, HHV4, HHV5 and HHV6 Ab levels. This led to the control of herpes in the family lineage: indeed, his daughter presented alterations of her serological herpes Ab levels.